Tobramycin Injection, Powder, For Solution
Product Images NDC 70436-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 70436-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Image 01)

FDA Label Image

Reduced-dosage-nomogram (Image 03)

Reduced-dosage-nomogram (Image 03)
This text describes a reduced dosage nomogram with scales for creatinine clearance (measured in mL/min/1.73 m2) and serum creatinine (measured in mg/100 mL) to facilitate dosage calculations. The table shows the percentage of normal dosage from Table 1 for different values of creatinine clearance.*
FDA Label Image

Vial Label (Image 04)

Vial Label (Image 04)
This is a pharmaceutical label for Tobramycin which is meant for intravenous use and should only be prepared by a licensed pharmacist. This package has no preservatives and contains Tobramycin sulfate, equalling 1200 or 1400mg per bulk pharmacy package. This label provides the necessary information on storage, dosing, and expiration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.